Solx Receives $2,250,000 New Funding

  • Feed Type
  • Date
    9/11/2015
  • Company Name
    Solx
  • Mailing Address
    230 Second Ave. Waltham, MA 02451 USA
  • Company Description
    The SOLX Glaucoma Treatment System is the next generation treatment platform that has the potential to change the current approach to glaucoma therapy.
  • Website
    http://www.solx.com
  • Transaction Type
    Debt
  • Transaction Amount
    $2,250,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities or debt.
  • M&A Terms
  • Venture Investor
    Undisclosed